Thorac Cardiovasc Surg 2012; 60(05): 360-362
DOI: 10.1055/s-0031-1295565
Short Communication
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Low-Volume, Single-Shot Crystalloid Cardioplegia is Safe for Isolated Aortic Valve Replacement

Peter Matt
1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
*   These authors contributed equally to this work
,
Emilio Arbeleaz
1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
*   These authors contributed equally to this work
,
Goetz Schwirtz
1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
,
Thomas Doebele
1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
,
Friedrich Eckstein
1   Clinic for Cardiac Surgery Basel, Heart Surgery Center Basel-Bern, Switzerland
› Author Affiliations
Further Information

Publication History

12 January 2011

21 July 2011

Publication Date:
29 December 2011 (online)

Preview

Abstract

We report our experience with a low-volume (100 mL), single-shot crystalloid cardioplegia (Cardioplexol) in 61 consecutive patients undergoing isolated aortic valve replacement (AVR). Cardioplexol resulted in immediate cardiac arrest. Intraoperative courses were uneventful. Postoperative markers of myocardial damage, Troponin T and CK-MB levels, were low but steadily increased with longer cross-clamp time. Thirty-day mortality was 3% and all noncardiac. Cardioplexol not only simplifies and speeds up the procedure but also seems to be safe for patients undergoing AVR.